InsiderTrades.com logo

BMRN Insider Trading

Insider Ownership Percentage: 0.68%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $1,555,389.29

BioMarin Pharmaceutical Insider Trading History Chart

This chart shows the insider buying and selling history at BioMarin Pharmaceutical by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

BioMarin Pharmaceutical Share Price & Price History

Current Price: $66.64
Price Change: ▼ Price Decrease of -0.72 (-1.07%)
As of 08/17/2026 04:00 PM ET

This chart shows the closing price history over time for BMRN up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

BioMarin Pharmaceutical Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
5/7/2026Gregory R FribergEVPSell3,281$53.85$176,681.8551,818View SEC Filing Icon  
3/11/2026Charles Greg GuyerEVPSell16,486$60.46$996,743.5679,953View SEC Filing Icon  
2/26/2026Gregory R FribergEVPSell6,326$60.38$381,963.8837,578View SEC Filing Icon  
5/20/2025Erin BurkhartCAOSell1,786$59.31$105,927.6614,173View SEC Filing Icon  
5/2/2025Cristin HubbardEVPSell273$64.92$17,723.1632,700View SEC Filing Icon  
3/19/2025Erin BurkhartCAOSell1,295$71.52$92,618.4016,955View SEC Filing Icon  
2/24/2025Erin BurkhartCAOSell1,344$68.38$91,902.7213,105View SEC Filing Icon  
11/12/2024Charles Greg GuyerEVPSell5,278$66.37$350,300.8668,909View SEC Filing Icon  
5/30/2024Brian R. MuellerCFOSell5,000$75.19$375,950.0072,159View SEC Filing Icon  
5/28/2024George Eric DavisEVPSell40,850$74.51$3,043,733.5056,157View SEC Filing Icon  
5/9/2024Jean Jacques BienaimeDirectorSell20,000$81.62$1,632,400.00474,994View SEC Filing Icon  
5/2/2024George Eric DavisEVPSell1,850$85.01$157,268.5056,157View SEC Filing Icon  
4/12/2024Jean Jacques BienaimeDirectorSell20,000$91.26$1,825,200.00474,994View SEC Filing Icon  
4/10/2024Erin BurkhartCAOSell2,286$90.00$205,740.0016,156View SEC Filing Icon  
3/28/2024George Eric DavisEVPSell24,602$88.34$2,173,340.6855,856View SEC Filing Icon  
3/5/2024Henry J. FuchsInsiderSell35,341$85.18$3,010,346.38212,117View SEC Filing Icon  
3/5/2024Jean Jacques BienaimeDirectorSell1,000$85.51$85,510.00561,203View SEC Filing Icon  
3/5/2024Jeffrey Robert AjerEVPSell4,000$87.07$348,280.0094,047View SEC Filing Icon  
2/27/2024Jean Jacques BienaimeDirectorSell1,000$90.35$90,350.00562,203View SEC Filing Icon  
2/9/2024Jean Jacques BienaimeDirectorSell15,000$88.28$1,324,200.00419,602View SEC Filing Icon  
1/9/2024Jean Jacques BienaimeDirectorSell10,000$98.19$981,900.00425,162View SEC Filing Icon  
12/21/2023Jean Jacques BienaimeDirectorSell10,000$93.99$939,900.00425,112View SEC Filing Icon  
12/13/2023George Eric DavisEVPSell13,764$95.30$1,311,709.2055,710View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for BioMarin Pharmaceutical (NASDAQ:BMRN)

98.71% of BioMarin Pharmaceutical stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at BMRN by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

BioMarin Pharmaceutical Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
8/17/2026Boone Capital Management LLC583,219$33.37M7.8%N/A0.301%Search for SEC Filing on Google Icon
8/15/2026Freestone Grove Partners LP364,194$20.84M0.1%N/A0.188%Search for SEC Filing on Google Icon
8/15/2026Caisse de depot et placement du Quebec1,236,446$70.75M0.1%N/A0.639%Search for SEC Filing on Google Icon
8/15/2026Trails Edge Capital Partners LP512,000$29.30B4.7%N/A0.264%Search for SEC Filing on Google Icon
8/15/2026Elmind Capital LP47,000$2.69B0.7%N/A0.024%Search for SEC Filing on Google Icon
8/14/2026ADAR1 Capital Management LLC49,000$2.80M0.1%N/A0.025%Search for SEC Filing on Google Icon
8/14/2026Hsbc Holdings PLC307,543$17.64M0.0%N/A0.159%Search for SEC Filing on Google Icon
8/14/2026EFG International AG18,400$1.05M0.0%N/A0.010%Search for SEC Filing on Google Icon
8/14/2026Primecap Management Co. CA14,190,183$811.96M0.5%N/A7.331%Search for SEC Filing on Google Icon
8/14/2026Canada Pension Plan Investment Board224,900$12.87M0.0%N/A0.116%Search for SEC Filing on Google Icon
8/14/2026Legal & General Group Plc537,468$30.75M0.0%N/A0.278%Search for SEC Filing on Google Icon
8/14/2026The Manufacturers Life Insurance Company 141,317$8.09M0.0%N/A0.073%Search for SEC Filing on Google Icon
8/14/2026Algert Global LLC118,440$6.78M0.1%-28.9%0.061%Search for SEC Filing on Google Icon
8/13/2026Sanctuary Advisors LLC4,841$0.28M0.0%N/A0.003%Search for SEC Filing on Google Icon
8/13/2026Connor Clark & Lunn Investment Management Ltd.9,545$0.55M0.0%N/A0.005%Search for SEC Filing on Google Icon
8/13/2026Meiji Yasuda Asset Management Co Ltd.7,780$0.45M0.0%N/A0.004%Search for SEC Filing on Google Icon
8/12/2026Northwestern Mutual Wealth Management Co.35,863$2.05M0.0%N/A0.019%Search for SEC Filing on Google Icon
8/12/2026Evolve Private Wealth LLC4,456$0.26M0.0%N/A0.002%Search for SEC Filing on Google Icon
8/12/2026Landscape Capital Management L.L.C.5,596$0.32M0.0%N/A0.003%Search for SEC Filing on Google Icon
8/12/2026Ieq Capital LLC197,988$11.33M0.1%N/A0.102%Search for SEC Filing on Google Icon
8/11/2026Keating Financial Advisory Services Inc.975$56K0.0%N/A0.001%Search for SEC Filing on Google Icon
8/11/2026Paralel Advisors LLC40,919$2.34M0.1%N/A0.021%Search for SEC Filing on Google Icon
8/11/2026Allworth Financial LP5,963$0.34M0.0%N/A0.003%Search for SEC Filing on Google Icon
8/11/2026NFJ Investment Group LLC67,991$3.89M0.1%N/A0.035%Search for SEC Filing on Google Icon
8/11/2026Vise Technologies Inc.5,374$0.31M0.0%N/A0.003%Search for SEC Filing on Google Icon
8/11/2026E Fund Management Co. Ltd.7,246$0.42M0.0%N/A0.004%Search for SEC Filing on Google Icon
8/11/2026Edmond DE Rothschild Holding S.A.687,030$39.31M0.5%N/A0.355%Search for SEC Filing on Google Icon
8/10/2026Eagle Health Investments LP624,676$35.74M5.9%N/A0.323%Search for SEC Filing on Google Icon
8/7/2026Citizens Financial Group Inc. RI4,281$0.25M0.0%N/A0.002%Search for SEC Filing on Google Icon
8/7/2026Grandfield & Dodd LLC18,243$1.04M0.1%N/A0.009%Search for SEC Filing on Google Icon
8/7/2026Pallas Capital Advisors LLC6,941$0.40M0.0%N/A0.004%Search for SEC Filing on Google Icon
8/7/2026Deutsche Bank AG126,286$7.23M0.0%N/A0.065%Search for SEC Filing on Google Icon
8/7/2026Rice Hall James & Associates LLC248,224$14.20M0.7%N/A0.128%Search for SEC Filing on Google Icon
8/7/2026Mitsubishi UFJ Asset Management Co. Ltd.683$39K0.0%N/A0.000%Search for SEC Filing on Google Icon
8/7/2026Monaco Asset Management SAM184,937$10.58M0.8%N/A0.096%Search for SEC Filing on Google Icon
8/7/2026Persistent Asset Partners Ltd79,933$4.57M1.4%N/A0.041%Search for SEC Filing on Google Icon
8/7/2026Plato Investment Management Ltd2,024$0.12M0.0%N/A0.001%Search for SEC Filing on Google Icon
8/6/2026Global Retirement Partners LLC4,906$0.28M0.0%N/A0.003%Search for SEC Filing on Google Icon
8/6/2026Bank of New York Mellon Corp1,155,305$66.11M0.0%N/A0.598%Search for SEC Filing on Google Icon
8/6/2026Focus Partners Advisor Solutions LLC10,899$0.62M0.0%N/A0.006%Search for SEC Filing on Google Icon
8/6/2026State of Wyoming9,980$0.57M0.1%N/A0.005%Search for SEC Filing on Google Icon
8/6/2026GSA Capital Partners LLP16,501$0.94M0.1%N/A0.009%Search for SEC Filing on Google Icon
8/3/2026Summit Global Investments32,667$1.87M0.1%N/A0.017%Search for SEC Filing on Google Icon
7/10/2026Handelsbanken Fonder AB62,700$3.59M0.0%+7.2%0.032%Search for SEC Filing on Google Icon
7/9/2026Everhart Financial Group Inc.6,995$0.40M0.0%+34.2%0.004%Search for SEC Filing on Google Icon
7/8/2026Assenagon Asset Management S.A.1,762,086$100.83M0.1%-8.3%0.912%Search for SEC Filing on Google Icon
7/7/2026GAMMA Investing LLC2,422$0.14M0.0%+43.5%0.001%Search for SEC Filing on Google Icon
7/2/2026Versant Capital Management Inc2,549$0.15M0.0%+310.5%0.001%Search for SEC Filing on Google Icon
6/18/2026Pacer Advisors Inc.23,643$1.34M0.0%-97.5%0.012%Search for SEC Filing on Google Icon
6/3/2026NewEdge Advisors LLC24,351$1.38M0.0%+2.2%0.013%Search for SEC Filing on Google Icon
6/1/2026Caerus Investment Advisors LLC4,905$0.28M0.1%-52.1%0.003%Search for SEC Filing on Google Icon
5/26/2026Glenmede Trust Co. NA7,552$0.43M0.0%-15.9%0.004%Search for SEC Filing on Google Icon
5/21/2026Essential Partners LLC8,777$0.50M0.2%-50.2%0.005%Search for SEC Filing on Google Icon
5/19/2026Edgestream Partners L.P.34,055$1.92M0.1%-73.0%0.018%Search for SEC Filing on Google Icon
5/19/2026Bull Harbor Capital LLC19,207$1.09M0.3%N/A0.010%Search for SEC Filing on Google Icon
5/18/2026ADAR1 Capital Management LLC18,200$1.03M0.1%+41.1%0.009%Search for SEC Filing on Google Icon
5/18/2026Amundi188,536$10.65M0.0%-4.6%0.098%Search for SEC Filing on Google Icon
5/18/2026EverSource Wealth Advisors LLC6,845$0.39M0.0%+12.3%0.004%Search for SEC Filing on Google Icon
5/18/2026California State Teachers Retirement System214,859$12.14M0.0%+23.9%0.111%Search for SEC Filing on Google Icon
5/18/2026Redmile Group LLC173,859$9.82M0.7%N/A0.090%Search for SEC Filing on Google Icon
5/18/2026Rubric Capital Management LP440,560$24.89M0.3%N/A0.228%Search for SEC Filing on Google Icon
5/18/2026Eagle Health Investments LP505,809$28.57M5.0%+37.9%0.262%Search for SEC Filing on Google Icon
5/18/2026Elmind Capital LP47,000$2.66M0.8%-42.7%0.024%Search for SEC Filing on Google Icon
5/18/2026Empowered Funds LLC33,203$1.88M0.0%+12.8%0.017%Search for SEC Filing on Google Icon
5/18/2026Eversept Partners LP207,768$11.74M0.6%+121.6%0.107%Search for SEC Filing on Google Icon
5/16/2026The Manufacturers Life Insurance Company133,750$7.56M0.0%-1.7%0.069%Search for SEC Filing on Google Icon
5/16/2026Quantinno Capital Management LP52,147$2.95M0.0%+41.2%0.027%Search for SEC Filing on Google Icon
5/16/2026SummitTX Capital L.P.90,632$5.12M0.2%+129.7%0.047%Search for SEC Filing on Google Icon
5/15/2026Rice Hall James & Associates LLC104,659$5.91M0.3%+4.5%0.054%Search for SEC Filing on Google Icon
5/15/2026Waverly Advisors LLC6,676$0.38M0.0%+32.0%0.003%Search for SEC Filing on Google Icon
5/14/2026Renaissance Technologies LLC1,024,871$57.90M0.1%-22.6%0.530%Search for SEC Filing on Google Icon
5/14/2026Public Employees Retirement System of Ohio56,590$3.20M0.0%-9.5%0.029%Search for SEC Filing on Google Icon
5/14/2026Caxton Associates LLP49,308$2.79M0.1%-67.7%0.026%Search for SEC Filing on Google Icon
5/14/2026Inceptionr LLC30,726$1.74M0.4%+73.8%0.016%Search for SEC Filing on Google Icon
5/14/2026Systematic Financial Management LP255,354$14.43M0.3%+0.4%0.132%Search for SEC Filing on Google Icon
5/14/2026Lido Advisors LLC5,719$0.32M0.0%N/A0.003%Search for SEC Filing on Google Icon
5/13/2026First Trust Advisors LP1,672,491$94.48M0.1%+43.3%0.865%Search for SEC Filing on Google Icon
5/12/2026Westpac Banking Corp12,997$0.73M0.1%-49.3%0.007%Search for SEC Filing on Google Icon
5/8/2026PNC Financial Services Group Inc.14,589$0.82M0.0%+5.2%0.008%Search for SEC Filing on Google Icon
5/7/2026Dimensional Fund Advisors LP3,802,930$214.80M0.0%+14.5%1.968%Search for SEC Filing on Google Icon
5/7/2026Parallel Advisors LLC1,768$100K0.0%+33.9%0.001%Search for SEC Filing on Google Icon
5/7/2026KBC Group NV127,194$7.19M0.0%-24.6%0.066%Search for SEC Filing on Google Icon
5/7/2026SEB Asset Management AB293,277$16.57M0.1%N/A0.152%Search for SEC Filing on Google Icon
5/7/2026Swiss National Bank361,100$20.40M0.0%+0.4%0.187%Search for SEC Filing on Google Icon
5/7/2026AIA Group Ltd7,707$0.44M0.0%-45.5%0.004%Search for SEC Filing on Google Icon
5/6/2026California Public Employees Retirement System490,715$27.72M0.0%-7.0%0.254%Search for SEC Filing on Google Icon
5/6/2026Assetmark Inc.22,875$1.29M0.0%+20.0%0.012%Search for SEC Filing on Google Icon
5/6/2026Bessemer Group Inc.89,439$5.05M0.0%+41.9%0.046%Search for SEC Filing on Google Icon
5/5/2026D.A. Davidson & CO.44,063$2.49M0.0%+467.1%0.023%Search for SEC Filing on Google Icon
5/5/2026Bank of New York Mellon Corp1,144,892$64.68M0.0%-35.5%0.592%Search for SEC Filing on Google Icon
5/5/2026Illinois Municipal Retirement Fund132,890$7.51M0.1%-22.6%0.069%Search for SEC Filing on Google Icon
5/5/2026Aubrey Capital Management Ltd7,500$0.42M0.2%-41.8%0.004%Search for SEC Filing on Google Icon
5/5/2026Sanctuary Advisors LLC8,765$0.50M0.0%-6.3%0.005%Search for SEC Filing on Google Icon
5/4/2026State of Michigan Retirement System46,200$2.61M0.0%+1.8%0.024%Search for SEC Filing on Google Icon
5/4/2026Principal Financial Group Inc.428,607$24.21M0.0%+3.8%0.222%Search for SEC Filing on Google Icon
5/4/2026Chicago Partners Investment Group LLC12,183$0.66M0.0%+2.4%0.006%Search for SEC Filing on Google Icon
5/4/2026J. Safra Sarasin Holding AG43,719$2.47M0.0%+41.7%0.023%Search for SEC Filing on Google Icon
5/1/2026Citizens Financial Group Inc. RI4,915$0.28M0.0%N/A0.003%Search for SEC Filing on Google Icon
5/1/2026Fifth Third Bancorp62,991$3.56M0.0%+7,695.9%0.033%Search for SEC Filing on Google Icon
5/1/2026Torray Investment Partners LLC78,170$4.42M0.6%N/A0.040%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
BioMarin Pharmaceutical logo
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-acetylgalactosamine 4-sulfatase for patients with MPS VI; and Kuvan, a proprietary synthetic oral form of 6R-BH4 that is used to treat patients with phenylketonuria (PKU), an inherited metabolic disease. The company's commercial products also comprise Palynziq, a PEGylated recombinant phenylalanine ammonia lyase enzyme, which is delivered through subcutaneous injection to reduce blood Phe concentrations; Brineura, a recombinant human tripeptidyl peptidase 1 for the treatment of patients with ceroid lipofuscinosis type 2, a form of Batten disease; Voxzogo, a once daily injection analog of c-type natriuretic peptide for the treatment of achondroplasia; and Aldurazyme, a purified protein designed to be identical to a naturally occurring form of the human enzyme alpha-L-iduronidase. In addition, it develops Roctavian, an adeno associated virus vector, for the treatment of patients with severe hemophilia A. The company serves specialty pharmacies, hospitals, and non-U.S. government agencies, as well as distributors and pharmaceutical wholesalers in the United States, Europe, Latin America, and internationally. BioMarin Pharmaceutical Inc. has license and collaboration agreements with Sarepta Therapeutics, Ares Trading S.A., Catalyst Pharmaceutical Partners, Inc. The company was incorporated in 1996 and is headquartered in San Rafael, California.
Read More on BioMarin Pharmaceutical

Today's Range

Now: $66.64
Low: $66.21
High: $67.63

50 Day Range

MA: $59.56
Low: $54.69
High: $70.24

52 Week Range

Now: $66.64
Low: $49.26
High: $70.98

Volume

2,237,795 shs

Average Volume

2,094,638 shs

Market Capitalization

$12.90 billion

P/E Ratio

180.11

Dividend Yield

N/A

Beta

0.24

Who are the company insiders with the largest holdings of BioMarin Pharmaceutical?

BioMarin Pharmaceutical's top insider shareholders include:
  1. Jean Jacques Bienaime (Director)
  2. Jean Jacques Bienaime (CEO)
  3. Henry J Fuchs (Insider)
  4. Henry J Fuchs (EVP)
  5. Robert Baffi (EVP)
  6. George Eric Davis (EVP)
  7. Richard A Meier (Director)
  8. Jeffrey Robert Ajer (EVP)
  9. Charles Greg Guyer (EVP)
  10. Brian Mueller (CFO)
Learn More about top insider investors at BioMarin Pharmaceutical.

Who are the major institutional investors of BioMarin Pharmaceutical?

BioMarin Pharmaceutical's top institutional investors include:
  1. Primecap Management Co. CA — 7.33%
  2. Assenagon Asset Management S.A. — 0.91%
  3. Caisse de depot et placement du Quebec — 0.64%
  4. Bank of New York Mellon Corp — 0.60%
  5. Edmond DE Rothschild Holding S.A. — 0.35%
  6. Eagle Health Investments LP — 0.32%
Learn More about top institutional investors of BioMarin Pharmaceutical stock.

Which major investors are selling BioMarin Pharmaceutical stock?

During the previous quarter, BMRN stock was sold by these institutional investors:
  1. Assenagon Asset Management S.A.
  2. Algert Global LLC
During the previous year, company insiders that have sold BioMarin Pharmaceutical company stock include:
  1. Charles Greg Guyer (EVP)
  2. Gregory R Friberg (EVP)
Learn More investors selling BioMarin Pharmaceutical stock.

Which major investors are buying BioMarin Pharmaceutical stock?

During the last quarter, BMRN stock was bought by institutional investors including:
  1. Primecap Management Co. CA
  2. Caisse de depot et placement du Quebec
  3. Bank of New York Mellon Corp
  4. Edmond DE Rothschild Holding S.A.
  5. Eagle Health Investments LP
  6. Boone Capital Management LLC
  7. Legal & General Group Plc
  8. Trails Edge Capital Partners LP

BioMarin Pharmaceutical Active Insiders

Jean Jacques Bienaime
Jean Jacques Bienaime (Age 73)
CEO
Cristin Hubbard
Cristin Hubbard
Executive Vice President, Chief Commercial Officer
Brian Mueller
Brian Mueller (Age 52)
CFO
Erin Burkhart
Erin Burkhart
CAO
Richard A Meier (Age 65)
Director
V Bryan Lawlis
Director
Michael G Grey
Michael G Grey
Director
Dennis Slamon
Dennis Slamon
Director
David E I Pyott
David E I Pyott
Director
Willard H Dere
Willard H Dere
Director
Mark J Alles
Mark J Alles
Director
Jeffrey Robert Ajer
Jeffrey Robert Ajer (Age 64)
EVP
George Eric Davis
George Eric Davis (Age 55)
EVP
Charles Greg Guyer
Charles Greg Guyer
EVP
1 recent trades
Gregory R Friberg
Gregory R Friberg
EVP
2 recent trades
Henry J Fuchs
Henry J Fuchs (Age 67)
Insider